Adherence to ESC guideline-recommended medications over a 36-month follow-up period after hospitalization for heart failure: Results from the EPICAL2 cohort study.
Fiche publication
Date publication
juillet 2019
Journal
Pharmacoepidemiology and drug safety
Auteurs
Membres identifiés du Cancéropôle Est :
Pr ROSSIGNOL Patrick, Pr THILLY Nathalie
Tous les auteurs :
Bitar S, Agrinier N, Alla F, Rossignol P, Mebazaa A, Thilly N
Lien Pubmed
Résumé
The purpose of the study is to describe the trajectories of oral medication prescriptions in patients with heart failure with reduced ejection fraction (HFrEF) over 3 years after discharge from hospitalization for heart failure. We then evaluated the adherence of these prescriptions to the European Society of Cardiology (ESC) guideline-recommended medications and identified patient characteristics associated with nonadherence.
Mots clés
adherence to guideline-recommended medications, associated factors, heart failure with reduced ejection fraction, pharmacoepidemiology, trajectories of medication prescriptions
Référence
Pharmacoepidemiol Drug Saf. 2019 Jul 24;: